Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

10

Revenue 2017

Amgen

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Amgen's 2013 sales performance.

Amgen

Amarin hits jackpot with astonishing heart benefits from fish oil product

Amarin hits jackpot with astonishing heart benefits from fish oil product

Achieving a reduction of 25% in major adverse CV events (MACE) is an uncommon achievement (though Amgen's Repatha achieved a similar effect) but the product's relatively low cost and

Teva wins FDA OK for crucial migraine drug

Teva wins FDA OK for crucial migraine drug Teva wins FDA OK for crucial migraine drug. Vital to Teva's turnaround, Ajovy will challenge Novartis/Amgen's Aimovig. ... 900 before rebates and discounts – exactly the same level as Novartis and Amgen positioned Aimovig, and in line with stablished

Boehringer bolts on another immuno-oncology company

Boehringer bolts on another immuno-oncology company Oncolytic virus-based therapies are consistent with and complement that strategy.”. The first oncolytic virus therapy to reach western markets was Amgen’s Imlygic (talimogene laherparepvec or T-Vec) which was

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline

Sanofi swaps execs with Bayer, looks to staunch diabetes, cardio decline It is struggling to compete with Amgen’s Repatha, earning just $73m in the second quarter compared to its rival’s $148m.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Congress Effectiveness Management
Maximising the ROI of scientific meetings...
Shanghai
Biopharma's Future: Made in China
The world’s second biggest pharma market is entering a new growth phase – but meeting its needs takes investment and expertise...
Solaris Health looks at the gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...

Infographics